Search clinical trials for: Enasidenib, dexamethasone, ixazomib, pomalidomide
Total 245 results
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Tel-Aviv Sourasky Medical CenterRecruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseIsrael
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Takeda; University Hospital, Grenoble; Nantes University... and other collaboratorsTerminatedMultiple Myeloma | Genetic Condition | Relapsed and Refractory Multiple MyelomaFrance
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Peking Union Medical College HospitalThe First Affiliated Hospital of Anhui Medical University; Peking University... and other collaboratorsRecruiting
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
Peking University People's HospitalQingdao Municipal HospitalRecruiting
-
Seagen Inc.Terminated
-
National University Hospital, SingaporeCelgeneUnknownMultiple Myeloma | Relapse After Use of Lenalidomide and BortezomibSingapore
-
IRCCS Policlinico S. MatteoCompletedPrimary Amyloidosis of Light Chain TypeItaly
-
Omar Nadeem, MDTakedaRecruitingMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Institute of Hematology & Blood Diseases HospitalRecruitingWaldenström MacroglobulinemiaChina
-
University of ArkansasWithdrawn
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Calithera Biosciences, IncCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHLUnited States
-
PETHEMA FoundationCelgene Corporation; Array BioPharmaCompleted
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Joseph TuscanoTakeda; CelgeneActive, not recruiting
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
Multinational Center for Quality of Life Research...Unknown
-
University of PennsylvaniaActive Biotech ABRecruiting
-
PfizerCompletedMultiple MyelomaCanada, United States
-
Threshold PharmaceuticalsUnknown
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
SanofiCompletedMultiple MyelomaFrance, Spain, Belgium, Australia, United States, Japan
-
Maimónides Biomedical Research Institute of CórdobaTerminated
-
University of LeedsTakeda; Cancer Research UKRecruitingMultiple MyelomaUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Plasmacytoma | Plasma Cell LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Biologics,...Active, not recruitingSolitary Osseous PlasmacytomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Institut CurieCelgene Corporation; Intergroupe Francophone du MyelomeCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Kosin University Gospel HospitalCompletedRelapsed and/or refractorY Multiple MyelomaKorea, Republic of